SOUTH SAN FRANCISCO, Calif., June 04, 2024 Cytokinetics, Incorporated today announced that on May 31, 2024 it granted stock options to purchase an aggregate of 53,417 shares of common stock,.
Cytokinetics Announces Closing of Public Offering of Common Stock marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
SOUTH SAN FRANCISCO, Calif., May 22, 2024 Cytokinetics, Incorporated today announced the pricing of an underwritten public offering of 9,803,922 shares of its common stock at a price to the.
Deal provides Cytokinetics with diversified access to capital as company advances its specialty cardiology franchise NEW YORK and SOUTH SAN FRANCISCO,.
SOUTH SAN FRANCISCO, Calif., May 17, 2024 Cytokinetics, Incorporated announced that the Company will host the muscle biology-focused Contemporary Landscapes in Muscle Biology Research Symposium.